Toursun Synbio
Latest round
- Angel
Last raised
- Sep 2025
Total raised
- Undisclosed
Investors
- 3
About Toursun Synbio
Based in Shanghai, China, and founded in 2023, Toursun Synbio is a biotechnology company focusing on artificial intelligence protein design services. The core team comes from Johns Hopkins University, Tsinghua University, and the Chinese Academy of Sciences. The founder and CEO, Yuguang Wang, graduated from the University of South Wales and is currently an associate professor at Shanghai Jiao Tong University. Toursun Synbio is committed to the research and development of the AI protein design platform ProteinEngine, which can accelerate enzyme modification and sequence design processes. It has been applied in multiple fields such as food, medicine, the chemical industry, and medical aesthetics. The company has made progress in product transformation in P450 protein, vanillin catalytic enzyme, vaccine antibody, etc. The company generates revenue by providing artificial intelligence protein design.
Who invested in Toursun Synbio
3 investors across 2 rounds
See all investors in Toursun Synbio
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Toursun Synbio
Who invested in Toursun Synbio?
Toursun Synbio has 3 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Toursun Synbio raised?
Toursun Synbio has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did Toursun Synbio last raise money?
Toursun Synbio's most recent round on record is a Angel, in Sep 2025.
What does Toursun Synbio do?
Based in Shanghai, China, and founded in 2023, Toursun Synbio is a biotechnology company focusing on artificial intelligence protein design services.
Where is Toursun Synbio headquartered?
Toursun Synbio is headquartered in Shanghai, China.
Which VCs invest in companies like Toursun Synbio?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Peak XV Partners, MPCi and Luminous Ventures back biotechnology companies at Toursun Synbio's stage. Their profiles are linked below.
VCs backing biotechnology startups at Angel
Raising like Toursun Synbio? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.